- Home
- USIO vs VNRX Comparison
USIO vs VNRX Comparison
Compare USIO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USIO | VNRX |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1M | 38.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | USIO | VNRX |
|---|---|---|
| Price | $1.35 | $0.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $4.00 | $2.50 |
| AVG Volume (30 Days) | 50.1K | ★ 2.3M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $83,710,461.00 | $1,472,007.00 |
| Revenue This Year | $5.99 | $55.98 |
| Revenue Next Year | $11.65 | $420.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.46 | ★ 14.48 |
| 52 Week Low | $1.24 | $0.22 |
| 52 Week High | $2.60 | $0.94 |
Technical Indicators
Market Signals| Indicator | USIO | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.39 | 43.81 |
| Support Level | $1.34 | $0.27 |
| Resistance Level | $1.40 | $0.35 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 10.53 | 5.33 |
Price Performance
Historical ComparisonAbout USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.